ResMed Inc.

NYSE: RMD · Real-Time Price · USD
284.96
0.24 (0.08%)
At close: Aug 15, 2025, 9:58 AM

ResMed Cash Flow Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2025 Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Net Income
1.4B 1.02B 897.56M 779.44M 474.5M
Depreciation & Amortization
235.81M 216.21M 197.56M 193.84M 191.52M
Stock-Based Compensation
91.66M 80.18M 71.14M 65.26M 63.93M
Other Working Capital
82.63M -127.42M -138.13M -168.11M -58.15M
Other Non-Cash Items
6.66M 39.13M -11.05M 20.69M 8.67M
Deferred Income Tax
n/a n/a 216K n/a -3.31M
Change in Working Capital
16.74M 44.78M -462.13M -708.08M 1.41M
Operating Cash Flow
1.75B 1.4B 693.3M 351.15M 736.72M
Capital Expenditures
-89.86M -114.86M -134M -156.04M -116.83M
Cash Acquisitions
-139.25M -133.46M -1.01B -42.78M -39.07M
Purchase of Investments
-6.42M -22.46M -32.23M -20.72M -21.79M
Sales Maturities Of Investments
n/a 1M 3.94M 6.8M n/a
Other Investing Acitivies
35.48M -15.4M 15.2M -17.18M 19.22M
Investing Cash Flow
-200.04M -269.78M -1.16B -229.92M -158.46M
Debt Repayment
-40M -730M 665M 122M -522M
Common Stock Repurchased
-300.02M -150.01M n/a n/a n/a
Dividend Paid
-310.88M -282.32M -258.28M -245.34M -226.71M
Other Financial Acitivies
-29.79M -10.05M -32.99M -52.41M -53.71M
Financial Cash Flow
-606.25M -1.12B 422.87M -128.36M -764.63M
Net Cash Flow
971.09M 10.47M -45.82M -21.57M -167.88M
Free Cash Flow
1.66B 1.29B 559.3M 195.11M 619.89M